RFI - 709154452 Development and manufacture of a Tranexamic Acid (TXA) Auto-Injector (AI)
The Ministry of Defence (MoD) are considering a requirement to develop a Tranexamic Acid Auto-Injector (TXA AI) containing 500mg/5ml formulation as soon as is technically possible, to reduce the need for clinical trials and gain UK MoD approval for off licence use. The UK MoD may subsequently seek an AI containing an improved formulation of TXA, by increasing concentration and reducing volume.
Buyer
Ministry of Defence
Value
Not provided
Published
18 Sept 2023
Closes
18 Sept 2023
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Not provided
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33692500
Injectable solutions
Lots
Lot default RFI - 709154452 Development and manufacture of a Tranexamic Acid (TXA) Auto-Injector (AI)
Value not provided
The Ministry of Defence (MoD) are considering a requirement to develop a Tranexamic Acid Auto-Injector (TXA AI) containing 500mg/5ml formulation as soon as is technically possible, to reduce the need for clinical trials and gain UK MoD approval for off licence use. The UK MoD may subsequently seek an AI containing an improved formulation of TXA, by increasin...
Delivery: British Oversea Territories, Channel Islands, Europe, Isle of Man, Rest of the World, United Kingdom
Documents
Unlock document linkEarly engagement notice on Contracts Finder
18 Sept 2023
Early engagement notice on Contracts Finder
Market engagement notice · Web page
Link to defence opportunity
Not provided
Link to defence opportunity
Document
Contains public sector information licensed under the Open Government Licence v3.0.